ARQT icon

Arcutis Biotherapeutics

139 hedge funds and large institutions have $1.06B invested in Arcutis Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.86M
Puts
$349K
Net Calls
Net Calls Change

Top Sellers

1 -$13.3M
2 -$9.18M
3 -$5.23M
4
Invesco
Invesco
Georgia
-$3.64M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.14M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.64M
52
$1.55M
53
$1.54M
54
$1.42M
55
$1.36M
56
$1.28M
57
$1.24M
58
$1.2M
59
$1.16M
60
$987K
61
$956K
62
$899K
63
$894K
64
$854K
65
$833K
66
$804K
67
$699K
68
$676K
69
$665K
70
$649K
71
$627K
72
$565K
73
$541K
74
$519K
75
$503K